Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival

Transplantation

Volumn 76, Issue 1, 2003, Pages 230-236

  Keil, Felix ^a   Prinz, Erika ^a   Moser, Karin ^a   Mannhalter, Christine ^b   Kalhs, Peter ^a   Worel, Nina ^a   Rabitsch, Werner ^a   Schulenburg, Axel ^a   Mitterbauer, Margit ^a   Greinix, Hildegard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Clin Inst Med/Chem Lab Diagn   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; FLUDARABINE;

ADULT; AGED; ALLOIMMUNITY; ARTICLE; BONE MARROW CELL; CELL KINETICS; CHIMERA; CLINICAL ARTICLE; FEMALE; GAMMA IRRADIATION; GRAFT REJECTION; GRAFT SURVIVAL; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LONG TERM CULTURE INITIATING CELL; LYMPHOID CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; T LYMPHOCYTE;

EID: 0037623948     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000071862.42835.76     Document Type: Article

References (25)

1. Molina AJ, Storb R. Hematopoietic stem cell transplantation in older adults. In: Rowe JM, Lazarus HM, Carella AM, eds. Handbook of bone barrow transplantation. London: Martin Dunitz 2000, pp 111-113.
2. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068-1073.
3. Weiden PL, Sullivan KM, Flournoy N, et al. Antileukemic effect of chronic graft-versus -host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529-1533.
4. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
5. Storb R, Yu C, Wagner JL, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997; 89(8): 3048-3054.
6. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97(11): 3390-3400.
7. Childs R, Clave E, Contentin N, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses. Blood 1999; 94: 3234-3241.
8. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
9. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.
10. Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2000; 29: 545-552.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Fritsch G, Buchinger P, Printz F, et al. Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. Blood 1993; 81: 2301-2309.
13. Keil F, Kalhs P, Chen X, et al. Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation. Ann Hematol 1999; 78: 376-379.
14. Keil F, Chen X, Louda N, et al. Effect of interleukin-3, stem cell factor and granulocyte-macrophage colony-stimulating factor on committed stem cells, long-term culture initiating cells and bone marrow stroma in a one-step long-term bone marrow culture. Ann Hematol 2000; 79(5): 243-248.
15. Keil F, Elahi F, Greinix HT, et al. Ex vivo expansion of long term culture initiating bone marrow cells by IL-10, SCF and IL-3. Transfusion 2002; 42:581-587.
16. Sutherland HJ, Eaves CJ, Eaves AC, et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563-1570.
17. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. J Immunol 1981; 126: 1614-1619.
18. Hogge DE, Lansdorp PM, Reid DB, et al. Enhanced detection, maintenance, and differentiation of primitive hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3 and granulocyte colony-stimulating factor. Blood 1996; 88: 3765-3773.
19. Rice A, Reiffers J, Bernard P, et al. Incomplete stroma formation after allogeneic marrow or autologous blood stem cell transplantation. Nouv Rev Fr Hematol 1992; 34(2): 167-174.
20. Selleri C, Maciejewski JP, De Rosa G, et al. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant. Bone Marrow Transplant 1999; 23(10): 1029-1037.
21. Keil F, Haas OA, Fritsch G, et al. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: Lack of residual donor hematopoiesis predicts aplasia. Blood 1997; 89(9): 3113-3117.
22. Keil F, Prinz E, Kalhs P, et al. Treatment of leukemic relapse after allogeneic stem cell transplantation with cytoreductive chemotherapy and/or immunotherapy or second transplants. Leukemia 2001; 15(3): 355-361.
23. Keil F, Kalhs P, Chen X, et al. Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation. Ann Hematol 1999; 78(8): 376-379.
24. Keil F, Kalhs P, Haas OA, et al. Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: Successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion. Br J Haematol 1996; 94(1): 120-122.
25. Georges GE, Storb R, Thompson JD, et al. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. Blood 2000; 95: 3262-3269.